Title : Capecitabine + Epirubicin + Cyclophosphamide Combination Therapy (CEX Therapy) as Neoadjuvant Chemotherapy for HER-2-Negative Breast Cancer: A Retrospective, Single-Center Study.

Pub. Date : 2020 May 15

PMID : 31776320






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Neoadjuvant chemotherapy of capecitabine + epirubicin + cyclophosphamide combination therapy ( "CEX" therapy) for HER-2 negative breast cancer, as retrospective study in our institute. Epirubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 BACKGROUND: We have modified and performed neoadjuvant chemotherapy (NAC) using capecitabine + epirubicin + cyclophosphamide combination therapy ( "CEX" ) for HER-2 negative breast cancer. Epirubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens